JD Supra February 23, 2023
By Tarter Krinsky & Drogin LLP

Recent cases of fraud and abuse in the healthcare industry serve as a reminder of the importance of healthcare law compliance and ethical medical business practices. One such case is the qui tam relator case against Arizona-based Modern Vascular, in which the federal government has formally joined in as a party in the complaint.

Background

The case alleges that Modern Vascular and many of its principals, affiliates, and investor physicians and podiatrists violated a variety of fraud and abuse laws, including the federal False Claims Act and the Anti-Kickback Statute.

Essentially, Modern Vascular is accused of engaging in a fraudulent scheme whereby physicians and podiatrists were encouraged or permitted to invest in the company’s office-based laboratories (OBLs) in exchange for...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Govt Agencies, Provider, Regulations
A novel idea for controlling chatbots
HIMSS25 Tackles AI, Cybersecurity and Workforce Readiness Amid Regulatory Uncertainty
AI competition is eating the world
Podcast: Jihye Han Compares First-In-Class Drug Regulation in the US and Europe
Prescribing Buprenorphine By Telehealth: Lessons From San Francisco Amidst A Changing Regulatory Landscape

Share This Article